mda-mb-468 glutathione content Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers MDA-MB-468 - an overview |
MDA MB 468 an overview ScienceDirect Topics Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD L1 in Triple Negative Breast Cancer Cells Cell lines MDA MB 468, MDA MB 231 and HCC38 show sensitivity to Download Scientific Diagram
Pay in 4 interest-free payments of $7.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



